Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization

Gastroenterology. 2022 Nov;163(5):1137-1144. doi: 10.1053/j.gastro.2022.07.006. Epub 2022 Jul 16.
No abstract available

MeSH terms

  • Child
  • Chronic Disease
  • Humans
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / drug therapy